California is investing $500M in therapy apps for youth. Advocates fear it won’t pay off.

FHS
April 26, 2024
10:50 am

With little pomp, California launched two apps at the start of the year offering free behavioral health services to youths to help them cope with everything from living with anxiety to body acceptance.

AbbVie is gunning for accelerated approval of antibody-drug conjugate after positive PhII data

AbbVie plans to explore accelerated approval for its antibody-drug conjugate as a monotherapy in non-small cell lung cancer following positive Phase II topline data. Telisotuzumab-vedotin,

November 30, 2023

Could a mushroom-derived product be the future of lung cancer prevention?

Researchers find that a mushroom-derived product, GLSF, shows promise in reducing lung toxicity and tumor development induced by tobacco smoke carcinogens in mice. The study

September 27, 2023

Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.